Concepedia

Ashish Kulkarni

AK

36

Publications

1.9K

Citations

23

H-Index

2010

Active since

Affiliations

University of Massachusetts Amherst(Current)

Brigham and Women's Hospital

Harvard University

Dana-Farber Cancer Institute

Harvard–MIT Division of Health Sciences and Technology

Ashish Kulkarni is an author at University of Massachusetts Amherst specializing in medicine, nanomedicine, and immunology.

ORCID

Top concepts

Publications per year

2010–2025

36

Publications

36

A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan et al. · Nature Biomedical Engineering · 2018 · 190 citations

, , +9

CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages

Anujan Ramesh, Sahana Kumar, Dipika Nandi et al. · Advanced Materials · 2019 · 181 citations

Carbohydrate-Based Label-Free Detection of <i>Escherichia coli</i> ORN 178 Using Electrochemical Impedance Spectroscopy

Xuefei Guo, Ashish Kulkarni, Amos Doepke et al. · Analytical Chemistry · 2011 · 144 citations

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity

Poulomi Sengupta, Sudipta Basu, Shivani Soni et al. · Proceedings of the National Academy of Sciences · 2012 · 133 citations · Full text

Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy

Anujan Ramesh, Anthony Brouillard, Sahana Kumar et al. · Biomaterials · 2019 · 109 citations · Full text

, , +9

Rows per page

1–5 of 36